FDA Alert: Florida Company’s Dietary Supplement Recalled for Containing Prescription Drug Ingredients

April 23, 2024

This is a reprint of an FDA Alert. STOP CLOPEZ CORP Issues Voluntary Worldwide Recall of Schwinnng Capsules Due to the Presence of Undeclared Nortadalafil When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the…

Read More
Video cover showing New York map with NYC inset. Title is Lux Lifestyle Fueled by Med Crimes

April 22, 2024: NY federal courts close cases involving fraud, second-hand HIV meds

April 22, 2024

The Southern District of New York sentenced criminals from two separate HIV drug diversion rings.

Read More

FDA alert: Counterfeit version of Botox found in multiple states

April 16, 2024

The products appear to have been purchased from unlicensed sources. Medications purchased from unlicensed sources may be misbranded, adulterated, counterfeit, contaminated, improperly stored and transported, ineffective and/or unsafe.

Read More

April 15, 2024: Fake Botox investigation expands to five states; six hospitalized

April 15, 2024

Cases of a botulism-like illness linked to cosmetic injections have been reported in Colorado, Illinois, Kentucky, Tennessee and Washington.

Read More

Florida’s final submission: November 2023 documents for its Canadian drug importation program

April 12, 2024

The state of Florida provided these FOIA-responsive documents to PSM for the state’s final and ultimately approved application to establish a Canadian drug importation program.

Read More
A vial of fake Botox

U.S. officials warn about botulism-like illness linked to counterfeit Botox

April 11, 2024

People in nine states sought medical treatment and some were hospitalized after receiving injections of fake Botox in what the CDC has characterized as “non-medical settings.”

Read More

Alternative funding programs offshore patients and import risks

April 5, 2024

Some employers are “saving money” on health insurance by hiring vendors to broker personal drug importation between their employees and unlicensed, illegal foreign pharmacies. Read more to understand the dangers of this cost-cutting practice.

Read More
an opaque yellow jar with writing in Korean and English

April 2, 2024: FDA warns against using unapproved, high-dose lidocaine topicals

April 2, 2024

Numbing creams that exceed the FDA-approved dose can cause irregular heartbeat, seizures and breathing difficulties. CBP has added FDA-regulated products to a pilot program to improve product traceability. Additional domestic and international news about medicine counterfeiting

Read More

The Partnership for Safe Medicines supports pharmacy benefit reforms in California Senate Bill 966

March 25, 2024

State Senator Scott Wiener’s bill would eliminate under-reimbursement practices that create a dangerous opportunity for criminals to enter the legitimate supply chain.

Read More
Pharmaceuticals laid out on a table as DEA evidence

March 25, 2024: Vegas man sentenced for illegal imported medicine scheme

March 25, 2024

A Las Vegas man was sentenced for money laundering as well as the illegal importation and sale of prescription opioids. Additional news across the U.S. and in India.

Read More